# Carlyle Group Inc.

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1527166. Source: https://holderbook.com/funds/1527166-carlyle-group-inc/

- Reported value: $10.0B
- Positions: 19
- Weight of the ten largest: 99.9%
- Filed: 2026-08-07

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| MEDLINE INC | [MDLN](https://holderbook.com/stocks/MDLN/) | $7.4B | 187,083,713 | 73.8% | 3 |
| STANDARDAERO INC | [SARO](https://holderbook.com/stocks/SARO/) | $2.5B | 84,587,035 | 25.3% | 7 |
| PHATHOM PHARMACEUTICALS INC | [PHAT](https://holderbook.com/stocks/PHAT/) | $37.9M | 3,496,808 | 0.4% | 14 |
| INVITATION HOMES INC | [INVH](https://holderbook.com/stocks/INVH/) | $20.0M | 662,900 | 0.2% | 14 |
| PONY AI INC | [PONY](https://holderbook.com/stocks/PONY/) | $16.4M | 2,362,447 | 0.2% | 7 |
| GETTY IMAGES HOLDINGS INC | [GETY](https://holderbook.com/stocks/GETY/) | $5.4M | 6,234,252 | 0.1% | 15 |
| SPRUCE BIOSCIENCES INC | [SPRB](https://holderbook.com/stocks/SPRB/) | $2.1M | 38,620 | 0.0% | 4 |
| SUNPOWER INC | [SPWR](https://holderbook.com/stocks/SPWR/) | $1.6M | 2,343,750 | 0.0% | 12 |
| ADICET BIO INC | [ACET](https://holderbook.com/stocks/ACET/) | $1.6M | 184,295 | 0.0% | 3 |
| FORWARD AIR CORP | [FWRD](https://holderbook.com/stocks/FWRD/) | $1.4M | 107,214 | 0.0% | 5 |
| ONKURE THERAPEUTICS INC | [OKUR](https://holderbook.com/stocks/OKUR/) | $1.2M | 269,895 | 0.0% | 7 |
| KRISPY KREME INC | [DNUT](https://holderbook.com/stocks/DNUT/) | $1.2M | 340,748 | 0.0% | 10 |
| Q32 BIO INC | [QTTB](https://holderbook.com/stocks/QTTB/) | $769.0K | 60,363 | 0.0% | 10 |
| RILEY EXPLORATION PERMIAN IN | [REPX](https://holderbook.com/stocks/REPX/) | $530.4K | 16,092 | 0.0% | 1 |
| NEBIUS GROUP N.V. | [NBIS](https://holderbook.com/stocks/NBIS/) | $509.8K | 1,846 | 0.0% | 1 |
| ROBINHOOD MKTS INC | [HOOD](https://holderbook.com/stocks/HOOD/) | $474.6K | 4,733 | 0.0% | 3 |
| JASPER THERAPEUTICS INC | [JSPR](https://holderbook.com/stocks/JSPR/) | $448.9K | 1,066,189 | 0.0% | 10 |
| N-ABLE INC | [NABL](https://holderbook.com/stocks/NABL/) | $344.0K | 93,732 | 0.0% | 10 |
| RAMACO RES INC | [METC](https://holderbook.com/stocks/METC/) | $287.7K | 21,743 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | -5.6% | +14.8% | -20.5% | 100% |
| Q1 2026 | +0.5% | -4.6% | +5.1% | 100% |
| Q4 2025 | +10.0% | +2.4% | +7.6% | 100% |
| Q3 2025 | -13.0% | +7.8% | -20.8% | 100% |
| Q2 2025 | +18.0% | +10.5% | +7.6% | 100% |
| Q1 2025 | -5.4% | -4.6% | -0.8% | 100% |
| Q4 2024 | -14.3% | +2.1% | -16.5% | 100% |
| Q3 2024 | +24.7% | +5.4% | +19.3% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $10.0B | 19 |
| Q1 2026 | $10.6B | 20 |
| Q4 2025 | $13.6B | 20 |
| Q3 2025 | $4.3B | 17 |
| Q2 2025 | $5.0B | 20 |
| Q1 2025 | $3.8B | 23 |
| Q4 2024 | $4.1B | 27 |
| Q3 2024 | $954.2M | 26 |
| Q2 2024 | $1.1B | 31 |
| Q1 2024 | $1.6B | 32 |
| Q4 2023 | $2.1B | 25 |
| Q3 2023 | $2.3B | 25 |